Independent Symposia

Thursday, October 3, 2019

7:10 AM - 7:55 AM

A First-line Biologic with Clinical Date vs Adalimumab and Secukinumab
Faculty: Stacy R. Smith, MD 
Sponsored by: Janssen

12:30 PM - 1:15 PM

Uncovering Clearance 
Introducing SKYRIZI for Adults with Moderate to Severe Plaque Psoriasis 

Faculty: Jennifer Soung, MD 
Sponsored by: AbbVie 

3:00 PM - 4:00 PM

Understanding Legal Tools: Keys to Lawsuit Prevention, License Protection and Tax Reduction
Faculty: Art McOmber
Sponsored by: Legally Mine 


Friday, October 4, 2019   

7:10 AM - 7:55 AM

Are Your Topical Patients Systemic-Ready? An Oral Treatment Option for Moderate to Severe Plaque Psoriasis
Faculty: Miriam Bettencourt, MD
Sponsored by: Celgene

9:25 AM - 10:25 AM

CME/CE provided for this session (Additional 1.0 AMA PRA Category 1 Credit) 
Atopic Dermatitis: Beneath the Surface
Individualizing Care for Patients with Moderate-to-Severe Disease

Faculty: Linda Stein Gold, MD
Supported by: Sanofi Genzyme and Regeneron Pharmaceuticals

12:15 PM - 1:00 PM

Dupixent: Visible results for Adolescents (12+ years of age) with Uncontrolled Moderate to-Severe Atopic Dermatitis
Faculty: Linda Stein Gold, MD
Sponsored by: Regeneron Healthcare Solutions 


Saturday, October 5, 2019

7:10 AM - 7:55 AM

Taltz Efficacy and Safety
Faculty:  Clive Liu, MD
Sponsored by: Lilly


Follow Us